Novel biomarkerssuch as cMyC, IMA, microRNAs, and copeptin enhance early diagnosis, monitoring, and prognosis of acute myocardial infarction beyondtraditional markers [17]. The gene discussed is AVP; the disease is acute myocardial infarction.